Search Results

1 - 10 of 208 items :

  • "vascular endothelial growth factor" x
Clear All
Serum vascular endothelial growth factor per platelet count in patients with biliary atresia

, Garcia-Buey L, Garcia-Arroyo A, Garcia-Sanchez A, Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology. 1995; 108:231-41. 12. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno- Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004; 39:1185-95. 13. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in

Open access
Vascular Endothelial Growth Factor (VEGF) in Abdominal Fluid in Dogs with Oncological and Non-Oncological Diseases

REFERENCES 1. Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25(4): 581-611. https://doi.org/10.1210/er.2003-0027 PMid:15294883 2. Pidgeon, G.P., Barr, M.P., Harmey, J.H., Foley, D.A., Bouchier-Hayes, D.J. (2001). Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer. 85(2): 273-278. https://doi.org/10.1054/bjoc.2001.1876 PMid:11461089 PMCid:PMC2364032 3. Takano, Т., Ohyama, T., Kokumoto

Open access
Vascular endothelial growth factor in prognosis of splenic malignant tumours in dogs

References 1. Aresu L., Aricò A., Comazzi S., Gelain M.E., Riondato F., Mortarino M., Morello E., Stefanello D., Castagnaro M.: VEGF and MMP-9: biomarkers for canine lymphoma. Vet Comp Oncol 2012, 10, 1476-1481. 2. Bałan B.J., Słotwiński R.: VEGF and tumor angiogenesis. Centr Eur J Immunol 2008, 33, 232-236. 3. Campos A.G., Campos J.A.D.B., Sanches D.S., Dagli M.L.Z., Matera J.M.: Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in splenic hemangiomas and hemangiosarcomas in dogs. Open

Open access
Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients

-9. 15. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003; 47: 149-61. 16. Tello-Montoliu A, Patel JV, Lip GYH. Angiogenin: a review of the patophysiology and potential clinical applications. J Thromb Haemost 2006; 4: 1864-4. 17. Gao X, Xu Z. Mechanisms of action of angiogenin. Acta Biochim Biophys Sin 2008; 40: 619-24. 18. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor

Open access
Adrenomedullin administration alters vascular endothelial growth factor levels in rats in cold stress

under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 2000; 19:5435. 9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6:389. 10. Harmey JH, Bouchier-Hayes D. Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. Bioessays. 2002: 24:280. 11. Rak J, Yu JL, Klement G, Kerbel RS. Oncogenes and angiogenesis: signaling three-dimensional tumor growth. J Investig

Open access
Assessment of Maturation Status of Tumor-Infiltrating Dendritic Cells in Invasive Ductal Carcinoma of the Breast: Relation with Vascular Endothelial Growth Factor Expression / Memenin İnvaziv Duktal Karsinomunda Tümör İnfiltrasyonu Yapan Dendritik Hücrelerin Olgunlaşma Durumunun Değerlendirilmesi: Vasküler Endotelyal Büyüme Faktörü İfadesiyle İlişki

, Mabuchi H, Nohara H, Gon G, Toyoda M, Tanigawa N: Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 2003, 104: 92-97 14. Maae E, Nielsen M, Steffensen KD, Jakobsen EH, Jakobsen A, Sørensen FB: Estimation of immunohistochemical expression of VEGF in ductal carcinomas of the breast. J Histochem Cytochem 2011, 59: 750-760 15. Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Batsis C, Pavlidis N, Agnantis NJ: The prognostic value of vascular endothelial growth factor

Open access
The Prognostic Role of Vascular Endothelial Growth Factor-A Expression in Thyroid Carcinomas

REFERENCES 1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49. 2. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19(11): 1167-214. 3. Niu G, Chen X. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets 2010; 11

Open access
Vascular Endothelial Growth Factor in Colonic Cancer, Ulcerative Colitis and Colonic Adenoma: An Immunohistochemical Study

D, Simopoulos C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol. 2003;56(3):209-13. 23. Kapsoritakis A, Sfiridaki A, Maltezos E, Simopoulos K, Giatromanolaki A, Sivridis E, Koukourakis MI. Vascular endothelial growth factor in inflammatory bowel disease. Int J Colorectal Dis. 2003;18(5):418-22. 24. Alkim C, Sakiz D, Alkim H, Livaoglu A, Kendir T, Demirsoy H, Erdem L, Akbayir N, Sokmen M. Thrombospondin-1 and VEGF in inflammatory bowel

Open access
The Importance of Vascular Endothelial Growth Factor as a Marker of Angiogenesis and Lymphangiogenesis in Non-small Cell Lung Cancer

-small cell lung carcinoma patients. Lung Cancer 2008;59:41–47. 11. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene. 2000;19:5598–5605. 12. O’Byrne KJ, Koukourakis MI, Giatromanolaki A, et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer. 2000;82:1427—1432. 13. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Invading edge vs. inner (edvin) patterns of

Open access
Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy

microvascular complications of diabetes among South Indian subjects with type 2 diabetes-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther. 2010;12(10):755-61. DOI: 10.1089/dia.2010.0069 4. Abbott CA, Chaturvedi N, Malik RA, Salgami E, Yates AP, Pemberton PW, et al. Explanations for the lower rates of diabetic neuropathy in Indian Asians Versus Europeans. Diabetes Care. 2010;33(6):1325-30. DOI: 10.2337/dc09-2067 5. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia

Open access